Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Medtronic Aims To Double Its Presence In Emerging Markets By 2015-2016

This article was originally published in The Gray Sheet

Executive Summary

In its first in-depth investor meeting in two years, Medtronic emphasized emerging markets, its ability to demonstrate economic worth, broad product offerings and pipeline as keys to growth.

You may also be interested in...

Positive Data For Threshold-Suspend Feature Of Medtronic Insulin Pump

Medtronic says the ability to automatically suspend insulin delivery when glucose levels drop to a preset threshold is an important technological milestone en route to a fully automated artificial pancreas.

FDA Audit Slows Down Medtronic Launch Plans For Low-Glucose-Suspend Diabetes System

A recent FDA inspection of Medtronic’s diabetes business identified quality systems deficiencies that are likely to delay the firm’s launch of its first-of-a-kind MiniMed 530G insulin pump/continuous glucose monitoring system.

Medtronic Emphasizes International Growth Opportunities

Medtronic is betting on emerging markets and the “value” market to be its major growth drivers over the next few years.

Related Content


Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts